Nalân Utku | OMICS International
ISSN: 2155-6105

Journal of Addiction Research & Therapy
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Nalân Utku

 Campus Virchow Institute for Medical Immunology, Institutsgebäude Süd Föhrer, 213353 Berlin, Germany


 Nalan Utku, MD co-founded CellAct Pharma GmbH and serves as Managing Director of its Research & Development. Dr. Utku founded GenPat77 Pharmacogenetics AG in 1998 and served as its President, Chief Scientific Officer and Chief Executive Officer. She has more than 18 years of experience in immunological research, thereof 10 years in commercial environments. She spent several years in clinical medicine at the departments of Neurology and Rheumatology at the Universityof Bonn and Transplant Immunology, Renal Division, Department of Medicine at Brigham and Women's Hospital, Harvard Medical School, Boston. She started as research fellow at the department of Medicine, Brigham and Womens's Hospital, Harvard Medical School, Boston, USA in 1993. She served as a Principal Investigator in the Department of Immunology of the Charité Hospital in Berlin, where she led her own research laboratory. Dr. Utku studied Medicine at the Universities of Münster, Bonn in Germany and Pittsburgh, Pennsylvania in the USA.

Research Interest


Global Speakers in the subject

Global Experts in the subject